Martin K Childers

Author PubWeight™ 28.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers. Proc Natl Acad Sci U S A 2010 1.64
2 Testosterone replacement therapy and motor function in men with spinal cord injury: a retrospective analysis. Am J Phys Med Rehabil 2008 1.43
3 Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies. Mamm Genome 2012 1.28
4 Kinematics of gait in golden retriever muscular dystrophy. Neuromuscul Disord 2009 1.13
5 Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy. Hum Mol Genet 2013 1.09
6 Effects of prednisone in canine muscular dystrophy. Muscle Nerve 2004 1.06
7 The paradox of muscle hypertrophy in muscular dystrophy. Phys Med Rehabil Clin N Am 2012 1.06
8 Muscle function in a canine model of X-linked myotubular myopathy. Muscle Nerve 2012 1.04
9 Eccentric contractions induce rapid isometric torque drop in dystrophin-deficient dogs. Muscle Nerve 2010 0.97
10 Selenoprotein N deficiency in mice is associated with abnormal lung development. FASEB J 2013 0.95
11 Establishing clinical end points of respiratory function in large animals for clinical translation. Phys Med Rehabil Clin N Am 2011 0.95
12 Golden retriever muscular dystrophy (GRMD): Developing and maintaining a colony and physiological functional measurements. Methods Mol Biol 2011 0.93
13 Aging and physical mobility in group-housed Old World monkeys. Age (Dordr) 2011 0.92
14 Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons. J Neuropathol Exp Neurol 2016 0.91
15 TCAP knockdown by RNA interference inhibits myoblast differentiation in cultured skeletal muscle cells. Neuromuscul Disord 2008 0.89
16 Mesenchymal stem cells: emerging therapy for Duchenne muscular dystrophy. PM R 2009 0.86
17 Ultrasound assessment of the diaphragm: Preliminary study of a canine model of X-linked myotubular myopathy. Muscle Nerve 2014 0.82
18 Testosterone levels among men with spinal cord injury admitted to inpatient rehabilitation. Am J Phys Med Rehabil 2006 0.81
19 A single-dose resveratrol treatment in a mouse model of amyotrophic lateral sclerosis. J Med Food 2010 0.81
20 Tarsal tunnel syndrome associated with a pulsating artery: effectiveness of high-resolution ultrasound in diagnosing tarsal tunnel syndrome. J Am Podiatr Med Assoc 2010 0.80
21 Aquatic versus land-based exercises as early functional rehabilitation for elite athletes with acute lower extremity ligament injury: a pilot study. PM R 2010 0.78
22 Gene therapy for inherited muscle diseases: where genetics meets rehabilitation medicine. Am J Phys Med Rehabil 2014 0.78
23 Syngeneic Myoblast Transplantation Improves Muscle Function in a Murine Model of X-Linked Myotubular Myopathy. Cell Transplant 2014 0.78
24 Guiding intramuscular diaphragm injections using real-time ultrasound and electromyography. Muscle Nerve 2015 0.77
25 Ambulation training with and without partial weightbearing after traumatic brain injury: results of a randomized, controlled trial. Am J Phys Med Rehabil 2006 0.77
26 Stretch-induced force deficits in murine extensor digitorum longus muscles after cardiotoxin injection. Muscle Nerve 2006 0.77
27 Respiratory assessment in centronuclear myopathies. Muscle Nerve 2014 0.77
28 Myostatin expression in muscular dystrophies and mitochondrial encephalomyopathies. Pediatr Neurol 2006 0.77
29 Effects of intra-articular botulinum toxin type A in an equine model of acute synovitis: a pilot study. Am J Phys Med Rehabil 2007 0.76
30 Disease-in-a-dish: the contribution of patient-specific induced pluripotent stem cell technology to regenerative rehabilitation. Am J Phys Med Rehabil 2014 0.76
31 Regenerative rehabilitation: a new future? Am J Phys Med Rehabil 2014 0.75
32 Immunofluorescence microscopy for imaging of nuclear p63 in human primary keratinocytes: a comparison of antibodies and fixation methods. J Immunol Methods 2009 0.75
33 Stem cell use in musculoskeletal disorders. PM R 2011 0.75